Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma.

Pulito C, Korita E, Sacconi A, Valerio M, Casadei L, Lo Sardo F, Mori F, Ferraiuolo M, Grasso G, Maidecchi A, Lucci J, Sudol M, Muti P, Blandino G, Strano S.

J Exp Clin Cancer Res. 2019 Aug 9;38(1):349. doi: 10.1186/s13046-019-1352-3.

2.

Monitoring Vitamin B12 in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic Diseases.

Mastroianni A, Ciniselli CM, Panella R, Macciotta A, Cavalleri A, Venturelli E, Taverna F, Mazzocchi A, Bruno E, Muti P, Berrino F, Verderio P, Morelli D, Pasanisi P.

Nutrients. 2019 May 7;11(5). pii: E1020. doi: 10.3390/nu11051020.

3.

miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.

Vahabi M, Pulito C, Sacconi A, Donzelli S, D'Andrea M, Manciocco V, Pellini R, Paci P, Sanguineti G, Strigari L, Spriano G, Muti P, Pandolfi PP, Strano S, Safarian S, Ganci F, Blandino G.

J Exp Clin Cancer Res. 2019 Mar 29;38(1):141. doi: 10.1186/s13046-019-1119-x.

4.

Salicylate enhances the response of prostate cancer to radiotherapy.

Broadfield LA, Marcinko K, Tsakiridis E, Zacharidis PG, Villani L, Lally JSV, Menjolian G, Maharaj D, Mathurin T, Smoke M, Farrell T, Muti P, Steinberg GR, Tsakiridis T.

Prostate. 2019 Apr;79(5):489-497. doi: 10.1002/pros.23755. Epub 2019 Jan 4.

PMID:
30609074
5.

Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.

Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, Anagnostopoulos AE, Wang A, Broadfield LA, Ford RJ, Foster RA, Bates J, Sun H, Wang T, Liu H, Ray AS, Saha AK, Greenwood J, Bhat S, Harriman G, Miao W, Rocnik JL, Westlin WF, Muti P, Tsakiridis T, Harwood HJ Jr, Kapeller R, Hoshida Y, Tanabe KK, Steinberg GR, Fuchs BC.

Cell Metab. 2019 Jan 8;29(1):174-182.e5. doi: 10.1016/j.cmet.2018.08.020. Epub 2018 Sep 20.

PMID:
30244972
6.

Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.

Ferraiuolo M, Pulito C, Finch-Edmondson M, Korita E, Maidecchi A, Donzelli S, Muti P, Serra M, Sudol M, Strano S, Blandino G.

Cancer Lett. 2018 Oct 1;433:18-32. doi: 10.1016/j.canlet.2018.06.021. Epub 2018 Jun 19.

7.

Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.

Tang GH, Satkunam M, Pond GR, Steinberg GR, Blandino G, Schünemann HJ, Muti P.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):627-635. doi: 10.1158/1055-9965.EPI-17-0936. Epub 2018 Apr 4.

8.

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.

Di Agostino S, Valenti F, Sacconi A, Fontemaggi G, Pallocca M, Pulito C, Ganci F, Muti P, Strano S, Blandino G.

Theranostics. 2018 Feb 12;8(7):1850-1868. doi: 10.7150/thno.22167. eCollection 2018.

9.

MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.

Frixa T, Sacconi A, Cioce M, Roscilli G, Ferrara FF, Aurisicchio L, Pulito C, Telera S, Carosi M, Muti P, Strano S, Donzelli S, Blandino G.

Carcinogenesis. 2018 Feb 9;39(2):293-304. doi: 10.1093/carcin/bgx134.

PMID:
29236960
10.

A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression.

Dufresne S, Rébillard A, Muti P, Friedenreich CM, Brenner DR.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):11-24. doi: 10.1158/1055-9965.EPI-16-0969. Epub 2017 Nov 15. Review.

11.

MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective study.

Muti P, Donzelli S, Sacconi A, Hossain A, Ganci F, Frixa T, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G.

Carcinogenesis. 2018 Feb 9;39(2):98-108. doi: 10.1093/carcin/bgx126.

12.

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

Lo Sardo F, Muti P, Blandino G, Strano S.

Int J Mol Sci. 2017 Sep 6;18(9). pii: E1913. doi: 10.3390/ijms18091913.

13.

Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy.

Secreto G, Muti P, Sant M, Meneghini E, Krogh V.

Endocr Relat Cancer. 2017 Nov;24(11):C21-C29. doi: 10.1530/ERC-17-0251. Epub 2017 Aug 16.

PMID:
28814452
14.

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Ganci F, Sacconi A, Manciocco V, Covello R, Benevolo M, Rollo F, Strano S, Valsoni S, Bicciato S, Spriano G, Muti P, Fontemaggi G, Blandino G.

Mod Pathol. 2017 Oct;30(10):1387-1401. doi: 10.1038/modpathol.2017.62. Epub 2017 Jul 21.

15.

Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, Campagnoli C, Berrino F, Fanciulli M, Ford RJ, Levrero M, Pediconi N, Ciuffreda L, Milella M, Steinberg GR, Cioce M, Muti P, Strano S, Blandino G.

Cell Discov. 2017 Jul 4;3:17022. doi: 10.1038/celldisc.2017.22. eCollection 2017.

16.

AMPK β1 reduces tumor progression and improves survival in p53 null mice.

Houde VP, Donzelli S, Sacconi A, Galic S, Hammill JA, Bramson JL, Foster RA, Tsakiridis T, Kemp BE, Grasso G, Blandino G, Muti P, Steinberg GR.

Mol Oncol. 2017 Sep;11(9):1143-1155. doi: 10.1002/1878-0261.12079. Epub 2017 Jun 28.

17.

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Muti P, Secreto G, Krogh V.

Breast Cancer Res Treat. 2017 Jun;163(3):631-632. doi: 10.1007/s10549-017-4194-8. Epub 2017 Mar 18. No abstract available.

PMID:
28315966
18.

MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.

Canu V, Sacconi A, Lorenzon L, Biagioni F, Lo Sardo F, Diodoro MG, Muti P, Garofalo A, Strano S, D'Errico A, Grazi GL, Cioce M, Blandino G.

Oncotarget. 2017 May 2;8(18):29540-29557. doi: 10.18632/oncotarget.15290.

19.

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration.

Villani LA, Smith BK, Marcinko K, Ford RJ, Broadfield LA, Green AE, Houde VP, Muti P, Tsakiridis T, Steinberg GR.

Mol Metab. 2016 Aug 26;5(10):1048-1056. doi: 10.1016/j.molmet.2016.08.014. eCollection 2016 Oct.

20.

A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women.

Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V.

Breast Cancer Res Treat. 2016 Aug;158(3):553-61. doi: 10.1007/s10549-016-3901-1. Epub 2016 Jul 9.

PMID:
27393623
21.

Dietary Protective Effects Against Hepatocellular Carcinoma Development in Mdr2-/- Knockout Mice.

Gentileschi MP, Lattanzio C, Menicagli F, Vincenzi B, Cigliana G, Baldi A, Blandino G, Muti P, Fanciulli M, Spugnini EP.

In Vivo. 2016 Jul-Aug;30(4):445-50.

PMID:
27381607
22.

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or ...both?

Cioce M, Strano S, Muti P, Blandino G.

Aging (Albany NY). 2016 May;8(5):1153-5. doi: 10.18632/aging.100965. No abstract available.

23.

Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.

Conti S, Gallo E, Sioletic S, Facciolo F, Palmieri G, Lauriola L, Evoli A, Martucci R, Di Benedetto A, Novelli F, Giannarelli D, Deriu G, Granone P, Ottaviano M, Muti P, Pescarmona E, Marino M.

J Thorac Dis. 2016 Mar;8(3):386-95. doi: 10.21037/jtd.2016.02.40.

24.

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Mori F, Ferraiuolo M, Santoro R, Sacconi A, Goeman F, Pallocca M, Pulito C, Korita E, Fanciulli M, Muti P, Blandino G, Strano S.

Oncotarget. 2016 Apr 12;7(15):20532-48. doi: 10.18632/oncotarget.7978.

25.

MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.

Donzelli S, Cioce M, Muti P, Strano S, Yarden Y, Blandino G.

Semin Cell Dev Biol. 2016 Feb;50:133-42. doi: 10.1016/j.semcdb.2015.12.020. Epub 2016 Jan 7. Review.

PMID:
26773212
26.

Comet Assay in Cancer Chemoprevention.

Santoro R, Ferraiuolo M, Morgano GP, Muti P, Strano S.

Methods Mol Biol. 2016;1379:99-105. doi: 10.1007/978-1-4939-3191-0_9.

PMID:
26608293
27.

Use of Buffy Coat miRNA Profiling for Breast Cancer Prediction in Healthy Women.

Donzelli S, Blandino G, Muti P.

Methods Mol Biol. 2016;1379:13-9. doi: 10.1007/978-1-4939-3191-0_2.

PMID:
26608286
28.

Epigenetic silencing of miR-145-5p contributes to brain metastasis.

Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, Carosi MA, Pescarmona E, Segatto O, Pond G, Muti P, Telera S, Strano S, Yarden Y, Blandino G.

Oncotarget. 2015 Nov 3;6(34):35183-201. doi: 10.18632/oncotarget.5930.

29.

Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes.

Cancarini I, Krogh V, Agnoli C, Grioni S, Matullo G, Pala V, Pedraglio S, Contiero P, Riva C, Muti P, Sieri S.

PLoS One. 2015 Sep 16;10(9):e0138318. doi: 10.1371/journal.pone.0138318. eCollection 2015.

30.

What biomarkers (if any) for precise medicine?

Strano S, Muti P, Blandino G.

Aging (Albany NY). 2015 Aug;7(8):533-4. No abstract available.

31.

Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion.

Pulito C, Mori F, Sacconi A, Casadei L, Ferraiuolo M, Valerio MC, Santoro R, Goeman F, Maidecchi A, Mattoli L, Manetti C, Di Agostino S, Muti P, Blandino G, Strano S.

Oncotarget. 2015 Jul 20;6(20):18134-50.

32.

miR-181c associates with tumor relapse of high grade osteosarcoma.

Mori F, Sacconi A, Canu V, Ganci F, Novello M, Anelli V, Covello R, Ferraresi V, Muti P, Biagini R, Blandino G, Strano S.

Oncotarget. 2015 Jun 10;6(16):13946-61.

33.

Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.

O'Brien AJ, Villani LA, Broadfield LA, Houde VP, Galic S, Blandino G, Kemp BE, Tsakiridis T, Muti P, Steinberg GR.

Biochem J. 2015 Jul 15;469(2):177-87. doi: 10.1042/BJ20150122. Epub 2015 May 5.

PMID:
25940306
34.

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E.

PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015.

35.

MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.

Ganci F, Sacconi A, Manciocco V, Sperduti I, Battaglia P, Covello R, Muti P, Strano S, Spriano G, Fontemaggi G, Blandino G.

Head Neck. 2016 Apr;38 Suppl 1:E189-97. doi: 10.1002/hed.23969. Epub 2015 Jun 24.

PMID:
25532855
36.

microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Pulito C, Donzelli S, Muti P, Puzzo L, Strano S, Blandino G.

Ann Transl Med. 2014 Jun;2(6):58. doi: 10.3978/j.issn.2305-5839.2014.06.03. Review.

37.

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

Key TJ, Appleby PN, Reeves GK, Travis RC, Brinton LA, Helzlsouer KJ, Dorgan JF, Gapstur SM, Gaudet MM, Kaaks R, Riboli E, Rinaldi S, Manjer J, Hallmans G, Giles GG, Le Marchand L, Kolonel LN, Henderson BE, Tworoger SS, Hankinson SE, Zeleniuch-Jacquotte A, Koenig K, Krogh V, Sieri S, Muti P, Ziegler RG, Schairer C, Fuhrman BJ, Barrett-Connor E, Laughlin GA, Grant EJ, Cologne J, Ohishi W, Hida A, Cauley JA, Fourkala EO, Menon U, Rohan TE, Strickler HD, Gunter MJ; Endogenous Hormones and Breast Cancer Collaborative Group.

Steroids. 2015 Jul;99(Pt A):49-55. doi: 10.1016/j.steroids.2014.09.001. Epub 2014 Oct 7.

38.

Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study.

Muti P, Sacconi A, Hossain A, Donzelli S, Ben Moshe NB, Ganci F, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2471-81. doi: 10.1158/1055-9965.EPI-14-0398. Epub 2014 Jul 29.

39.

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.

Akl EA, Kahale L, Barba M, Neumann I, Labedi N, Terrenato I, Sperati F, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2014 Jul 8;(7):CD006650. doi: 10.1002/14651858.CD006650.pub4. Review. Update in: Cochrane Database Syst Rev. 2018 Jun 19;6:CD006650.

PMID:
25004410
40.

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.

Cioce M, Valerio M, Casadei L, Pulito C, Sacconi A, Mori F, Biagioni F, Manetti C, Muti P, Strano S, Blandino G.

Oncotarget. 2014 Jun 30;5(12):4129-43.

41.

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.

Akl EA, Kahale L, Sperati F, Neumann I, Labedi N, Terrenato I, Barba M, Sempos EV, Muti P, Cook D, Schünemann H.

Cochrane Database Syst Rev. 2014 Jun 26;(6):CD009447. doi: 10.1002/14651858.CD009447.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Jul 11;7:CD009447.

PMID:
24966161
42.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Kahale L, Neumann I, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2014 Jun 19;(6):CD006649. doi: 10.1002/14651858.CD006649.pub6. Review. Update in: Cochrane Database Syst Rev. 2018 Jan 24;1:CD006649.

43.

VDR primary targets by genome-wide transcriptional profiling.

Goeman F, De Nicola F, D'Onorio De Meo P, Pallocca M, Elmi B, Castrignanò T, Pesole G, Strano S, Blandino G, Fanciulli M, Muti P.

J Steroid Biochem Mol Biol. 2014 Sep;143:348-56. doi: 10.1016/j.jsbmb.2014.03.007. Epub 2014 Apr 13.

PMID:
24726990
44.

Tumor suppressor microRNAs: a novel non-coding alliance against cancer.

Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y.

FEBS Lett. 2014 Aug 19;588(16):2639-52. doi: 10.1016/j.febslet.2014.03.033. Epub 2014 Mar 26. Review.

45.

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.

Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, Srinathan S, Guyatt G, Cruz P, Graham M, Wang CY, Berwanger O, Pearse RM, Biccard BM, Abraham V, Malaga G, Hillis GS, Rodseth RN, Cook D, Polanczyk CA, Szczeklik W, Sessler DI, Sheth T, Ackland GL, Leuwer M, Garg AX, Lemanach Y, Pettit S, Heels-Ansdell D, Luratibuse G, Walsh M, Sapsford R, Schünemann HJ, Kurz A, Thomas S, Mrkobrada M, Thabane L, Gerstein H, Paniagua P, Nagele P, Raina P, Yusuf S, Devereaux PJ, Devereaux PJ, Sessler DI, Walsh M, Guyatt G, McQueen MJ, Bhandari M, Cook D, Bosch J, Buckley N, Yusuf S, Chow CK, Hillis GS, Halliwell R, Li S, Lee VW, Mooney J, Polanczyk CA, Furtado MV, Berwanger O, Suzumura E, Santucci E, Leite K, Santo JA, Jardim CA, Cavalcanti AB, Guimaraes HP, Jacka MJ, Graham M, McAlister F, McMurtry S, Townsend D, Pannu N, Bagshaw S, Bessissow A, Bhandari M, Duceppe E, Eikelboom J, Ganame J, Hankinson J, Hill S, Jolly S, Lamy A, Ling E, Magloire P, Pare G, Reddy D, Szalay D, Tittley J, Weitz J, Whitlock R, Darvish-Kazim S, Debeer J, Kavsak P, Kearon C, Mizera R, O'Donnell M, McQueen M, Pinthus J, Ribas S, Simunovic M, Tandon V, Vanhelder T, Winemaker M, Gerstein H, McDonald S, O'Bryne P, Patel A, Paul J, Punthakee Z, Raymer K, Salehian O, Spencer F, Walter S, Worster A, Adili A, Clase C, Cook D, Crowther M, Douketis J, Gangji A, Jackson P, Lim W, Lovrics P, Mazzadi S, Orovan W, Rudkowski J, Soth M, Tiboni M, Acedillo R, Garg A, Hildebrand A, Lam N, Macneil D, Mrkobrada M, Roshanov PS, Srinathan SK, Ramsey C, John PS, Thorlacius L, Siddiqui FS, Grocott HP, McKay A, Lee TW, Amadeo R, Funk D, McDonald H, Zacharias J, Villar JC, Cortés OL, Chaparro MS, Vásquez S, Castañeda A, Ferreira S, Coriat P, Monneret D, Goarin JP, Esteve CI, Royer C, Daas G, Chan MT, Choi GY, Gin T, Lit LC, Xavier D, Sigamani A, Faruqui A, Dhanpal R, Almeida S, Cherian J, Furruqh S, Abraham V, Afzal L, George P, Mala S, Schünemann H, Muti P, Vizza E, Wang CY, Ong GS, Mansor M, Tan AS, Shariffuddin II, Vasanthan V, Hashim NH, Undok AW, Ki U, Lai HY, Ahmad WA, Razack AH, Malaga G, Valderrama-Victoria V, Loza-Herrera JD, De Los Angeles Lazo M, Rotta-Rotta A, Szczeklik W, Sokolowska B, Musial J, Gorka J, Iwaszczuk P, Kozka M, Chwala M, Raczek M, Mrowiecki T, Kaczmarek B, Biccard B, Cassimjee H, Gopalan D, Kisten T, Mugabi A, Naidoo P, Naidoo R, Rodseth R, Skinner D, Torborg A, Paniagua P, Urrutia G, Maestre ML, Santaló M, Gonzalez R, Font A, Martínez C, Pelaez X, De Antonio M, Villamor JM, García JA, Ferré MJ, Popova E, Alonso-Coello P, Garutti I, Cruz P, Fernández C, Palencia M, Díaz S, Del Castillo T, Varela A, de Miguel A, Muñoz M, Piñeiro P, Cusati G, Del Barrio M, Membrillo MJ, Orozco D, Reyes F, Sapsford RJ, Barth J, Scott J, Hall A, Howell S, Lobley M, Woods J, Howard S, Fletcher J, Dewhirst N, Williams C, Rushton A, Welters I, Leuwer M, Pearse R, Ackland G, Khan A, Niebrzegowska E, Benton S, Wragg A, Archbold A, Smith A, McAlees E, Ramballi C, Macdonald N, Januszewska M, Stephens R, Reyes A, Paredes LG, Sultan P, Cain D, Whittle J, Del Arroyo AG, Sessler DI, Kurz A, Sun Z, Finnegan PS, Egan C, Honar H, Shahinyan A, Panjasawatwong K, Fu AY, Wang S, Reineks E, Nagele P, Blood J, Kalin M, Gibson D, Wildes T; Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Writing Group, on behalf of The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Investigators; Appendix 1. The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Study Investigators Writing Group; Appendix 2. The Vascular events In noncardiac Surgery patIents cOhort evaluatioN Operations Committee; Vascular events In noncardiac Surgery patIents cOhort evaluatioN VISION Study Investigators.

Anesthesiology. 2014 Mar;120(3):564-78. doi: 10.1097/ALN.0000000000000113.

PMID:
24534856
46.

Is progesterone a neutral or protective factor for breast cancer?

Muti P.

Nat Rev Cancer. 2014 Feb;14(2):146. doi: 10.1038/nrc3518-c1. Epub 2014 Jan 20. No abstract available.

PMID:
24442141
47.

MicroRNAs: short non-coding players in cancer chemoresistance.

Donzelli S, Mori F, Biagioni F, Bellissimo T, Pulito C, Muti P, Strano S, Blandino G.

Mol Cell Ther. 2014 Jun 1;2:16. doi: 10.1186/2052-8426-2-16. eCollection 2014. Review.

48.

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G.

Oncogene. 2014 Nov 13;33(46):5319-31. doi: 10.1038/onc.2013.476. Epub 2013 Nov 18.

49.

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

Ganci F, Sacconi A, Bossel Ben-Moshe N, Manciocco V, Sperduti I, Strigari L, Covello R, Benevolo M, Pescarmona E, Domany E, Muti P, Strano S, Spriano G, Fontemaggi G, Blandino G.

Ann Oncol. 2013 Dec;24(12):3082-8. doi: 10.1093/annonc/mdt380. Epub 2013 Oct 9.

50.

The association of depressive symptoms and pulmonary function in healthy adults.

Ochs-Balcom HM, Lainhart W, Mnatsakanova A, Charles LE, Violanti JM, Andrew ME, Freudenheim JL, Muti P, Trevisan M, Burchfiel CM, Schünemann HJ.

Psychosom Med. 2013 Oct;75(8):737-43. doi: 10.1097/PSY.0b013e3182a15672. Epub 2013 Aug 19.

Supplemental Content

Support Center